Latest Breaking News On - China medical system holdings ltd - Page 1 : comparemela.com

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by the National Medical Products Administration of China (NMPA). In 2020, CMS International Development and Management Ltd, a wholly-owned subsidiary of China Medical System Holdings Ltd obtained an exclusive license for the product from Zydus. CKD involves a gradual loss of functioning of kidneys and eventually leads to kidney failure.

Macau generalSharvil patelZydus lifesciencesChina medical system holdingsManagement ltdChina medical system holdings ltdNational medical products administration of chinaInternational developmentAhmedabad based zydus lifesciencesNational medical products administrationGreater chinaMedical system holdingsMainland chinaHong kong special administrative regionMacao special administrative regionBusiness news